14-05-2025 18:16 via medpagetoday.com

CAR T-Cell Therapy for Relapsed/Refractory Follicular Lymphoma

(MedPage Today) -- When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to treatment for some patients, with its high end durable response rates, and lengthy survival outcomes...
Read more »

Medical news



Similar Relief From Cancer-Related Pain With Two Radiotherapy Techniques
RFK Jr. Hammered on Funding Cuts, HHS Overhaul at House Hearing
House Committee Holds Marathon Markup for Bill That Includes $715B in Medicaid Cuts
Here's How We Know Vaccines Are Safe and Effective
Staffing Woes Tied to Physician Burnout
Mucus-Plugged Airways Linked to COPD Outcomes
FDA OKs New Drug for Lung Cancer With c-Met Overexpression
First Oral Therapy for Rare Adrenal Gland Tumors Gets Green Light From FDA
Backup Drug Gains Footing for Resistant Hypertension
Does It Matter if the U.S. Surgeon General Never Practiced Medicine?
EPA Announces Rollback for Some Biden-Era Limits on PFAS in Drinking Water
U.S. Overdose Deaths Fell 27% Last Year, but Remain Above Prepandemic Levels
Health Conditions & Depression; Addiction Experts Write Congress; Propecia & Suicide
HHS Eyes ACIP Vax Recs; FDA Warning Letters Stalled; RFK Jr. Adviser Dust-Up
Desktop versie